Stereotactic Radiosurgery for Pediatric versus Adult Brain Arteriovenous Malformations: A Multicenter Study
A presentation at the 2019 American Association of Neurological Surgeons Annual Scientific Meeting
15-Apr-2019 5:30 PM EDT
SAN DIEGO (April 15, 2019) — Winner of the Cerebrovascular Section Best Clinical Scientific Paper, Ching-Jen Chen, MD, presented his research, Stereotactic Radiosurgery for Pediatric versus Adult Brain Arteriovenous Malformations: A Multicenter Study, during the 2019 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting.
The aim of this international, multicenter, retrospective, matched-cohort study is to directly compare the outcomes after stereotactic radiosurgery (SRS) for brain arteriovenous malformations (AVM) in pediatric vs. adult patients.
Researchers performed a retrospective review of AVM patients who underwent SRS at eight institutions participating in the International Gamma Knife Research Foundation (IGKRF) from 1987-2014. Patients were categorized into pediatric (<18 years old) and adult (≥18 years old) cohorts and matched in a 1:1 ratio using propensity scores. Favorable outcome was defined as AVM obliteration, no post-SRS hemorrhage and no permanently symptomatic radiation-induced changes (RIC).
The outcomes following SRS for comparable AVMs in pediatric versus adult patients were not found to be appreciably different. SRS remains a reasonable treatment option for appropriately selected pediatric AVM patients who harbor a high cumulative lifetime hemorrhage risk. Age appears to be a poor predictor of AVM outcomes after SRS.
Author Block: Ching‑Jen Chen, MD (Charlottesville, Va.); Dale Ding, MD; Hideyuki Kano, MD; David Mathieu, MD; Douglas Kondziolka, MD; Rafael Rodriguez‑Mercado, MD; Inga Grills, MD; Gene Barnett, MD; Caleb Feliciano, MD; Dade Lunsford, MD; Jason Sheehan, MD, PhD.
Disclosure: The author reported no conflicts of interest.
Media Representatives: The 2019 AANS Annual Scientific Meeting website’s press section includes releases on highlighted scientific research, AANS officers and award winners and other relevant information about the 2019 program. Releases will be posted on the 2019 AANS Annual Scientific Meeting website. If you have interest in a topic related to neurosurgery or would like to interview a neurosurgeon — either onsite or via telephone — during or after the event, please contact Alice Kelsey, AANS associate executive director, via email at firstname.lastname@example.org.
About the 2019 AANS Annual Scientific Meeting: Attended by neurosurgeons, neurosurgical residents, medical students, neuroscience nurses, clinical specialists, physician assistants, allied health professionals and other medical professionals, the AANS Annual Scientific Meeting is the largest gathering of neurosurgeons in the nation, with an emphasis on the field’s latest research and technological advances. The scientific presentations accepted for the 2019 event will represent cutting-edge examples of the incredible developments taking place within the field of neurosurgery. Find additional information about the 2019 AANS Annual Scientific Meeting and the meeting program here.
About the AANS
Founded in 1931 as the Harvey Cushing Society, the American Association of Neurological Surgeons (AANS) is a scientific and educational association with more than 11,500 members worldwide. The AANS promotes the highest quality of patient care and advances the specialty of neurological surgery. Fellows of the AANS are board-certified by the American Board of Neurological Surgery, the Royal College of Physicians and Surgeons of Canada or the Mexican Council of Neurological Surgery, A.C. Neurosurgery is the medical specialty concerned with the prevention, diagnosis, treatment and rehabilitation of disorders that affect the spinal column, spinal cord, brain, nervous system and peripheral nerves.
For more information, visit www.AANS.org.